The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
05/15/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Update Estimated Total Program Funding Amount.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-12-PRORP-TRPA
Opportunity Category:
Discretionary
Posted Date:
May 15, 2012
Creation Date:
May 15, 2012
Original Closing Date for Applications:
Sep 25, 2012
Current Closing Date for Applications:
Sep 25, 2012
Archive Date:
Oct 25, 2012
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
3
Estimated Total Program Funding:
$3,600,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The Translational Research Partnership Award supports translational research that will accelerate the movement of promising ideas in orthopaedic research into clinical applications to benefit Warfighters with combat-relevant traumatic orthopaedic injuries. The award is designed to encourage multi-institutional, multidisciplinary research partnerships among two or three investigators (designated as partners) to accelerate the movement of promising research hypotheses into clinical application in a manner that would be less readily achievable through separate efforts. There must be at least one laboratory scientist and at least one clinician participating in the partnership.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
